scholarly journals Effect of Prolonged Overdose Sorbitol and Aspartame Administration on Serum Lipid Profile: Experimental Finding

2021 ◽  
Keyword(s):  
Lipid Profile ◽  
Serum Lipid ◽  
Experimental Finding ◽  
Serum Lipid Profile

Effect of billary sphincterotomy on serum lipid profile: A pilot study

2001 ◽  
Vol 120 (5) ◽  
pp. A576-A576
Author(s):  
E FOGEL ◽  
T IMPERIALE ◽  
B DEVERAUX ◽  
S SHERMAN ◽  
J WATKINS ◽  
...  
Keyword(s):  
Pilot Study ◽  
Lipid Profile ◽  
Serum Lipid ◽  
Serum Lipid Profile

Studies on serum lipid profile in hypertensive patient

2007 ◽  
Vol 16 (1) ◽  
Author(s):  
D Sarkar ◽  
SA Latif ◽  
MM Uddin ◽  
J Aich ◽  
SR Sutradhar ◽  
...  
Keyword(s):  
Hypertensive Patient ◽  
Lipid Profile ◽  
Serum Lipid ◽  
Serum Lipid Profile

Assessment of Serum Lipid Profile in patients with chronic Hepatitis C

2018 ◽  
Vol 8 (8) ◽  
Author(s):  
Tanveer Ul Hassan ◽  
Bilal Umar ◽  
Danish Malik ◽  
Shoaib Waris ◽  
Khalid Hussain ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Lipid Profile ◽  
Chronic Hepatitis C ◽  
Serum Lipid ◽  
Serum Lipid Profile

Serum Lipid Profile in Diffuse versus Limited Systemic Sclerosis Data from the SASS cohort

2018 ◽  
Vol 69 (2) ◽  
pp. 403-406
Author(s):  
Codrina Ancuta ◽  
Cristina Pomirleanu ◽  
Cristina Iordache ◽  
Magda Ecaterina Antohe ◽  
Rodica Chirieac ◽  
...  
Keyword(s):  
Systemic Sclerosis ◽  
Lipid Profile ◽  
Total Cholesterol ◽  
Serum Lipid ◽  
Total Cholesterol Level ◽  
Cross Sectional Study ◽  
Serum Lipid Profile ◽  
Serum Triglycerides ◽  
Cross Sectional ◽  
Topoisomerase 1

Data about lipoprotein changes and their link with cardiovascular disease and atherosclerosis in systemic sclerosis (SSc) are still challenging. We aimed to evaluate serum lipid profile of patients with SSc and to identify potential relation with different disease specific characteristics (clinical, serological, inflammatory tests) in a cross-sectional study. Standard assessments comprised SSc-related parameters (disease subtype, clinical spectrum, immunological tests) and lipid metabolism (total cholesterol and fractions, triglycerides). Impaired lipid profile (low serum HDL- and high LDL-cholesterol, increased serum triglycerides, slightly modification in total cholesterol level) significantly correlated with diffuse SSc, activity (EUSTAR) and severity (MEDSGER), as well as seropositivity for specific antibodies (anti-centromere and anti-topoisomerase 1). The dyslipidemic profile might represent a pathobiological pathway for atherosclerosis in SSc.

Sign in / Sign up

Export Citation Format

Share Document